Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myeloid-derived suppressor cells in cancer and cancer therapy
Samantha Lasser, Feyza Gül Özbay Kurt, Ihor Arkhypov, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 2, pp. 147-164
Closed Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 34
Dendritic Polymer‐Based Nanomedicines Remodel the Tumor Stroma: Improve Drug Penetration and Enhance Antitumor Immune Response
Yuxin Zhang, Zaixiang Fang, Dayi Pan, et al.
Advanced Materials (2024) Vol. 36, Iss. 25
Closed Access | Times Cited: 21
Defining myeloid-derived suppressor cells
Leila Akkari, Ido Amit, Vincenzo Bronte, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 12, pp. 850-857
Closed Access | Times Cited: 16
Gut Microbiota-Derived Butyrate Induces Epigenetic and Metabolic Reprogramming in Myeloid-Derived Suppressor Cells to Alleviate Primary Biliary Cholangitis
Rui Wang, Bo Li, Bingyuan Huang, et al.
Gastroenterology (2024) Vol. 167, Iss. 4, pp. 733-749.e3
Closed Access | Times Cited: 15
Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review)
Wenjuan Zeng, Haohan Liu, Yuanhao Mao, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 3
Closed Access | Times Cited: 10
Targeted modulation of myeloid-derived suppressor cells in the tumor microenvironment: Implications for cancer therapy
Yafeng Qi, Liying Zhang, Y Q Liu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117590-117590
Closed Access | Times Cited: 10
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment
Yanyan Zhang, Zhichao Yang, Yuchen Liu, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Fibrinogen: a new player and target on the formation of pre-metastatic niche in tumor metastasis
Yuxin Zhang, Zelin Li, Jiamao Zhang, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 207, pp. 104625-104625
Closed Access | Times Cited: 1
Near-infrared Photoimmunotherapy: mechanisms, applications, and future perspectives in cancer research
Donald O. Allen, Madeline JoAnna Szoo, Tessa D. van Bergen, et al.
Antibody Therapeutics (2025) Vol. 8, Iss. 1, pp. 68-85
Open Access | Times Cited: 1
Effect of Extracellular Vesicles Derived From Tumor Cells on Immune Evasion
Xixi Liu, Kenneth K.W. To, Qinsong Zeng, et al.
Advanced Science (2025)
Open Access | Times Cited: 1
Reinforcing cancer immunotherapy with engineered porous hollow mycobacterium tuberculosis loaded with tumor neoantigens
Minghui Chen, Jie Jiang, Hengyu Chen, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010150-e010150
Open Access | Times Cited: 1
Cancer vaccines: current status and future directions
Yi Zhou, Yuquan Wei, Xiaohe Tian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Monocytic myeloid-derived suppressor cells contribute to the exacerbation of bone destruction in periodontitis
Zhaocai Zhou, Chi Zhan, Wenchuan Li, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Digging Through the Complexities of Immunological Approaches in Emerging Osteosarcoma Therapeutics: A Comprehensive Narrative Review with Updated Clinical Trials
Consolato Sergi, Mervin Burnett, Eugeniu Jantuan, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 664-664
Open Access | Times Cited: 1
Turn cold tumors hot by reprogramming the tumor microenvironment
Xiangliang Yuan, Yi Xiao, Dihua Yu
Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 466-470
Closed Access | Times Cited: 1
Mechanisms by which obesity regulates inflammation and anti-tumor immunity in cancer
Cora E Miracle, Chelsea L. McCallister, Richard D Egleton, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 733, pp. 150437-150437
Closed Access | Times Cited: 7
Myeloid-derived suppressor cells in peripheral blood as predictive biomarkers in patients with solid tumors undergoing immune checkpoint therapy: systematic review and meta-analysis
Maximilian Möller, Vanessa Orth, Viktor Umansky, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Advances in and prospects of immunotherapy for prostate cancer
Deng Liu, Luofu Wang, Yanli Guo
Cancer Letters (2024) Vol. 601, pp. 217155-217155
Open Access | Times Cited: 5
Immunometabolism of ferroptosis in the tumor microenvironment
Gian Luca Lupica-Tondo, Emily N. Arner, Denis A. Mogilenko, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 5
Immune dynamics shaping pre-metastatic and metastatic niches in liver metastases: from molecular mechanisms to therapeutic strategies
Chang Zhu, J Liao, Yiyang Liu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Exosomal circular RNAs in tumor microenvironment: An emphasis on signaling pathways and clinical opportunities
Junshu Li, Wencheng Zhou, Huiling Wang, et al.
MedComm (2024) Vol. 5, Iss. 12
Open Access | Times Cited: 4
Circular RNAs as Key Regulators in Cancer Hallmarks: New Progress and Therapeutic Opportunities
Bashdar Mahmud Hussen, Snur Rasool Abdullah, Rohana Jaafar, et al.
Critical Reviews in Oncology/Hematology (2025), pp. 104612-104612
Open Access
Distinct immune signatures for predicting the immunotherapy efficacy of esophageal squamous cell carcinoma or adenocarcinoma
Peng Wu, Guohui Qin, Jinyan Liu, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access
Targeting immune checkpoints on myeloid cells: current status and future directions
Chuhan Ma, Yang Li, Min Li, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access
Page 1 - Next Page

Scroll to top